Jorey Chernett - 11 Nov 2026 Form 4/A - Amendment Insider Report for Starling Oncology, Inc. (STLN)

SEC form
4/A - Amendment
Accepted by SEC
13 Nov 2026, 21:43:08 UTC
Original report date
12 Nov 2026
Prior SEC filing
10 Nov 2026
Next SEC filing
13 Nov 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Jorey Chernett filed Form 4/A - Amendment for Starling Oncology, Inc. (STLN) on 13 Nov 2026.

Key facts

  • This page summarizes Jorey Chernett's Form 4/A - Amendment filing for Starling Oncology, Inc. (STLN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 13 Nov 2026, 21:43.

Change

  • Previous filing in this sequence was filed on 10 Nov 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002042077 Primary reporting owner

Chernett Jorey

Relationship
10%+ Owner

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STLN transaction Derivative

Call Option (STLN 19FEB27 $4C)

Purchase

Transaction value
Shares
+1,391
Change %
+28%
Price
$0.8000*
Shares after
6,391
Date
11 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
139,100
Exercise price
$4.00
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Jorey Chernett is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The reported transaction is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transaction, which the reporting person intends to disgorge to the Issuer.

SEC remarks

This Form 4/A is being filed solely to indicate that the Reporting Person is no longer subject to Section 16 reporting obligations and constitutes an exit filing for the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .